Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$2.5B
Avg Funding
$98.2M
Cities
20

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Redwood City, United States
$50.1M
raised

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$125.0M
raised

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$40.0M
raised

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$275.0M
raised

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saint Laurent, Canada
$4.6M
raised

Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Seattle, United States
$175.0M
raised

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$91.1M
raised

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$11.2M
raised

Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$9.3M
raised

MetaVia is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Las Vegas, United States
$7.2M
raised

Hydreight provides a completely compliant turnkey business model for health professionals to offer fully licensed medical & health services.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Alpharetta, United States
$12.5M
raised

Dogwood Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$3.7M
raised

Rocket Doctor AI offers AI-powered healthcare software and services that support virtual patient care across the full clinical journey.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$135.0M
raised

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$175.1M
raised

Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$345.1M
raised

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$575.0M
raised

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$700K
raised

Harvard Apparatus Regenerative Technology is a biotechnology firm developing esophageal implants for patients battling threatening condition

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$10.0M
raised

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$20.1M
raised

IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Dallas, United States
$2.5M
raised

MangoRx is a men’s digital health, wellness, and performance company.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$60.0M
raised

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$99.2M
raised

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$175.0M
raised

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Tórtola, Spain
$1.3M
raised

CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked